학술논문
Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases
Document Type
Article
Author
Source
In Molecular Therapy 6 March 2024 32(3):637-645
Subject
Language
ISSN
1525-0016